Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)



Status:Active, not recruiting
Conditions:Cancer, Cancer, Smoking Cessation
Therapuetic Areas:Oncology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:4/6/2019
Start Date:April 2, 2018
End Date:December 2019

Use our guide to learn which trials are right for you!

Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)

The goal of this study is to determine whether the novel smartphone application designed
specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than
the current standard smoking cessation app.

Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there
are systemic barriers to delivering smoking cessation interventions to cancer patients. One
solution for addressing these barriers is to give patients immediate access to smoking
cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging
and tailored to the specific needs of cancer patients, and can be integrated into routine
cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit
rates than the current standard smoking cessation app.

Inclusion Criteria:

- age 18 or older

- diagnosed with cancer in the past 12 months

- has smoked a cigarette (even a puff) in the past 30 days

- interested in learning skills to quit smoking

- willing to be randomly assigned to either smartphone application

- resides in US

- has at least daily access to their own smartphone

- knows how to login and download a smartphone application from the Apple app store or
Android Play app store

- willing and able to read in English

- not currently using cessation medications or enrolled in other smoking cessation
programs, and

- has never used the NCI's Quit Guide smartphone application.

- willing and able to complete one follow-up survey

- willing to provide email, phone, and mailing address.

Exclusion Criteria:

- The exclusion criteria are opposite of the inclusion criteria listed above.
We found this trial at
1
site
1100 Fairview Avenue North
Seattle, Washington 98109
(206) 667-5000
Principal Investigator: Jonathan B. Bricker, Ph.D.
Fred Hutchinson Cancer Research Center At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of...
?
mi
from
Seattle, WA
Click here to add this to my saved trials